BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21516380)

  • 21. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.
    Lorier M; Magallanes L; Ibarra M; Guevara N; Vázquez M; Fagiolino P
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers.
    Kirchheiner J; Kudlicz D; Meisel C; Bauer S; Meineke I; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Aug; 74(2):186-94. PubMed ID: 12891229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ketoprofen enantiomers after intravenous administration of racemate in camels: effect of gender.
    Al Katheeri NA; Wasfi IA; Lambert M; Saeed A; Khan IA
    J Vet Pharmacol Ther; 2000 Jun; 23(3):137-43. PubMed ID: 11110100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
    Landoni MF; Lees P
    Equine Vet J; 1995 Jul; 27(4):247-56. PubMed ID: 8536660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective pharmacokinetics and inversion of (R)- ketoprofen in healthy volunteers.
    Rudy AC; Liu Y; Brater C; Hall SD
    J Clin Pharmacol; 1998 Feb; 38(2S):3S-10S. PubMed ID: 9549653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
    López-Rodríguez R; Novalbos J; Gallego-Sandín S; Román-Martínez M; Torrado J; Gisbert JP; Abad-Santos F
    Pharmacol Res; 2008 Jul; 58(1):77-84. PubMed ID: 18694831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of rheumatoid arthritis in the enantioselective disposition of fenoprofen.
    Barissa GR; Poggi JC; Donadi EA; Dos Reis ML; Lanchote VL
    Chirality; 2004 Nov; 16(9):602-8. PubMed ID: 15390088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High performance capillary electrophoresis for determination of the enantiomers of 2-arylpropionic acid derivatives in human serum. Pharmacokinetic studies of ketoprofen enantiomers following administration of standard and sustained release tablets.
    Główka FK; Karaźniewicz M
    J Pharm Biomed Anal; 2004 Jun; 35(4):807-16. PubMed ID: 15193725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
    Soraci AL; Tapia O; Garcia J
    J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of ketoprofen enantiomers in human serum by capillary zone electrophoresis: man pharmacokinetic studies after administration of rac-ketoprofen tablets.
    Główka FK
    J Pharm Biomed Anal; 2002 Nov; 30(4):1035-45. PubMed ID: 12408894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
    Kirchheiner J; Roots I; Goldammer M; Rosenkranz B; Brockmöller J
    Clin Pharmacokinet; 2005; 44(12):1209-25. PubMed ID: 16372821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of buffering on pharmacokinetics of ketoprofen enantiomers in man.
    Fuder H; Stiegler S; Wetzelsberger N; Wieckhorst G; Lange R; Lücker PW
    Br J Clin Pharmacol; 1997 Dec; 44(6):527-30. PubMed ID: 9431826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dimethicone (polysilane gel) on the stereoselective pharmacokinetics of ketoprofen.
    Presle N; Lapicque F; Gillet P; Herrmann MA; Bannwarth B; Netter P
    Eur J Clin Pharmacol; 1998 Jun; 54(4):351-4. PubMed ID: 9696963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of renal function on the pharmacokinetics of unchanged and acyl-glucuroconjugated ketoprofen enantiomers after 50 and 100 mg racemic ketoprofen.
    Skeith KJ; Dasgupta M; Lange R; Jamali F
    Br J Clin Pharmacol; 1996 Aug; 42(2):163-9. PubMed ID: 8864313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic and safety evaluations of ketoprofen gels in subjects with adult periodontitis.
    Lawrence HP; Paquette DW; Smith PC; Maynor G; Wilder R; Mann GL; Binder T; Troullos E; Annett M; Friedman M; Offenbacher S
    J Dent Res; 1998 Nov; 77(11):1904-12. PubMed ID: 9823729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enantioselective pharmacokinetics of ketoprofen in calves after intramuscular administration of a racemic mixture.
    Plessers E; Watteyn A; Wyns H; Pardon B; De Baere S; De Backer P; Croubels S
    J Vet Pharmacol Ther; 2015 Aug; 38(4):410-3. PubMed ID: 25410631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine.
    Wang Z; Wang S; Huang M; Hu H; Yu L; Zeng S
    Chirality; 2014 Mar; 26(3):166-73. PubMed ID: 24464553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantiospecific ketoprofen concentrations in plasma after oral and intramuscular administration in growing pigs.
    Mustonen K; Niemi A; Raekallio M; Heinonen M; Peltoniemi OA; Palviainen M; Siven M; Peltoniemi M; Vainio O
    Acta Vet Scand; 2012 Sep; 54(1):55. PubMed ID: 22998765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of dexketoprofen.
    Barbanoj MJ; Antonijoan RM; Gich I
    Clin Pharmacokinet; 2001; 40(4):245-62. PubMed ID: 11368291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.